Conexeu Sciences is trading at $3.40, up 11.11%, with the reason for the rebound unclear.

  • No new company announcement was listed on October 19; the latest press release was the October 15 private-placement announcement.
  • The approximately $5 million placement was intended to fund working capital, manufacturing scale-up, regulatory testing, and preclinical work.
  • Available coverage does not establish that the earlier financing caused the rebound.